Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sumanta K Pal

Showing results (1-10 of 404) with videos related to

Pageof 41
Sort By:
Oncoimmunology|April 9, 2016
Breaking bad habits: Targeting MDSCs to alleviate immunosuppression in prostate cancerSumanta K Pal, Marcin Kortylewski
Cancer Discovery|December 4, 2019
Precision Oncology for Hepatocellular Cancer: Slivering the Liver by FGF19-FGF4-KLB Pathway InhibitionVivek Subbiah, Sumanta K Pal
Nature Reviews. Clinical Oncology|July 30, 2014
Prostate cancer: the best fit for enzalutamide in metastatic prostate cancerSumanta K Pal, Oliver Sartor
European Urology|July 7, 2022
Aberrant Splice Variants: A Novel Characterization of Clear Cell Renal Cell CarcinomaJozefina Casuscelli, Sumanta K Pal
Nature Reviews. Clinical Oncology|November 15, 2012
Abiraterone and its place in the treatment of metastatic CRPCOliver Sartor, Sumanta K Pal
Nature Reviews. Urology|July 29, 2018
Cytoreductive nephrectomy: questions remain after CARMENASumeet Bhanvadia, Sumanta K Pal
European Urology Focus|July 8, 2025
Renal Cell Carcinoma: What Are the Unmet Needs?Nazli Dizman, Sumanta K Pal
Nature Medicine|March 10, 2026
Microbiome modulation in cancer immunotherapySumanta K Pal, Diwakar Davar
Nature Reviews. Urology|June 29, 2016
Kidney cancer: Finding a niche for girentuximab in metastatic renal cell carcinomaSumanta K Pal, Neeraj Agarwal
BJU International|November 7, 2015
Cabazitaxel for the therapy of metastatic castration-resistant prostate cancer in the aftermath of the CHAARTED trialSumanta K Pal, Guru Sonpavde
Pageof 41

Showing results (1-10 of 404) with videos related to

Sort By:
Pageof 41
Oncoimmunology|April 9, 2016
Breaking bad habits: Targeting MDSCs to alleviate immunosuppression in prostate cancerSumanta K Pal, Marcin Kortylewski
Cancer Discovery|December 4, 2019
Precision Oncology for Hepatocellular Cancer: Slivering the Liver by FGF19-FGF4-KLB Pathway InhibitionVivek Subbiah, Sumanta K Pal
Nature Reviews. Clinical Oncology|July 30, 2014
Prostate cancer: the best fit for enzalutamide in metastatic prostate cancerSumanta K Pal, Oliver Sartor
European Urology|July 7, 2022
Aberrant Splice Variants: A Novel Characterization of Clear Cell Renal Cell CarcinomaJozefina Casuscelli, Sumanta K Pal
Nature Reviews. Clinical Oncology|November 15, 2012
Abiraterone and its place in the treatment of metastatic CRPCOliver Sartor, Sumanta K Pal
Nature Reviews. Urology|July 29, 2018
Cytoreductive nephrectomy: questions remain after CARMENASumeet Bhanvadia, Sumanta K Pal
European Urology Focus|July 8, 2025
Renal Cell Carcinoma: What Are the Unmet Needs?Nazli Dizman, Sumanta K Pal
Nature Medicine|March 10, 2026
Microbiome modulation in cancer immunotherapySumanta K Pal, Diwakar Davar
Nature Reviews. Urology|June 29, 2016
Kidney cancer: Finding a niche for girentuximab in metastatic renal cell carcinomaSumanta K Pal, Neeraj Agarwal
BJU International|November 7, 2015
Cabazitaxel for the therapy of metastatic castration-resistant prostate cancer in the aftermath of the CHAARTED trialSumanta K Pal, Guru Sonpavde
Pageof 41